MELD-score for risk stratification in cardiac surgery

Area of Science:

• Cardiology
• Nephrology
• Hepatology

Background:

• Cardiac surgery outcomes are influenced by renal and hepatic function.
• Current risk scores like EURO Score II and STS do not quantify these organ functions.
• The Model for End-Stage Liver Disease (MELD) score, typically used for liver disease, can be applied to assess risk in cardiac surgery patients.

Purpose of the Study:

• To evaluate the MELD score as a predictor of mortality in patients undergoing cardiac surgery with cardiopulmonary bypass.
• To compare the predictive value of the MELD score against traditional risk stratification methods.

Main Methods:

• Retrospective analysis of 10,882 patient records.
• Patients were grouped by MELD score: <10 (Group 1), 10-19 (Group 2), and ≥20 (Group 3).
• Primary outcome: postoperative in-hospital mortality. Secondary outcomes included bleeding, neurological complications, and need for support.

Main Results:

• A higher MELD score correlated with increased postoperative mortality (Group 3: 31.2% vs. Group 1: 4.6%).
• Group 3 also showed higher rates of bleeding, repeat thoracotomy, pneumonia, and need for dialysis or mechanical support.
• MELD score did not significantly correlate with stroke/TIA or sternal wound infections.

Conclusions:

• The MELD score is a valuable tool for predicting mortality and complications in cardiac surgery patients.
• Applying the MELD score can enhance risk stratification beyond existing scores, particularly for patients with compromised renal and hepatic function.
• Consideration of the MELD score is recommended prior to cardiac surgery to better inform patient selection and management.